YBGJ
Yubo International Biotech LtdCompany Information
- Company Name
- Yubo International Biotech Ltd
- CIK
- CIK0000895464
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- YBGJ: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- YBGJ
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2024-07-15
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 7,040,140
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 66.15%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Class A | - | - | - | - | - | - | - | 0 | 2 | 118 | - | - | ||||||
| Common Class B | - | - | - | - | - | - | - | -0 | 0 | 0 | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets | ||||||||||||||||||
| Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 3 | 3 | 3 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | ||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | - | 1 | - | - | - | - | - | ||||||
| Customer Advances And Deposits Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 3 | 3 | 3 | 3 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | ||||||
Commitments And Contingencies Disclosure | ||||||||||||||||||
| Commitments And Contingencies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | - | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 5 | 5 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -3 | -2 | -2 | -2 | -4 | -4 | -3 | -3 | -2 | -2 | -2 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -8 | -8 | -8 | -7 | -7 | -7 | -7 | -6 | -6 | -5 | -5 | -4 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | ||||||
| Minority Interest In Joint Ventures | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Minority Interest | -0 | -0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialYubo International Biotech Ltd (YBGJ) — SEC Financial Statements & Analysis
Yubo International Biotech Ltd (YBGJ) is a electromedical & electrotherapeutic apparatus company, incorporated in NY. Yubo International Biotech Ltd trades on OTC as: YBGJ. Yubo International Biotech Ltd (YBGJ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, On profitability, Yubo International Biotech Ltd posts a gross margin of 80.65%, an operating margin of -8085.74%, a net margin of -8282.55%, a Return on Equity (ROE) of 30.83%, and a Return on Assets (ROA) of -118.71%. Per share, it reports diluted EPS of $-0.01. Over the trailing year, it posted revenue growth of -68727.78% year-over-year and net income growth of -41.94% year-over-year. On the balance sheet, it maintains a current ratio of 0.18x, a quick ratio of 0.13x, working capital of $-2.74M, a debt-to-equity ratio of -1.25x, a debt ratio of 4.95, an interest coverage ratio of -55490.67x, free cash flow of $-727.99K (TTM), and net debt of $-11.99K. Figures sourced from SEC EDGAR.
- ROE TTM
- 30.83%
- ROA TTM
- -118.71%
- Debt To Equity
- -1.25x
- Free Cash Flow TTM
- $-727.99K
- Net Revenue TTM Growth 1Y
- -68727.78%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Yubo International Biotech Ltd in?
Yubo International Biotech Ltd (YBGJ) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does YBGJ trade on?
Yubo International Biotech Ltd (YBGJ) trades on the OTC.
Where is Yubo International Biotech Ltd incorporated?
Yubo International Biotech Ltd is incorporated in NY.
When was Yubo International Biotech Ltd (YBGJ)'s most recent SEC filing?
Yubo International Biotech Ltd (YBGJ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is YBGJ's ROE (return on equity)?
Yubo International Biotech Ltd (YBGJ)'s trailing twelve month Return on Equity (ROE) is 30.83% as of 2026-06-30.
What is YBGJ's ROA (return on assets)?
Yubo International Biotech Ltd (YBGJ)'s trailing twelve month Return on Assets (ROA) is -118.71% as of 2026-06-30.